Koh-E-Fiza Hospital And Research Profile
Key Indicators
- Authorised Capital ₹ 7.00 M
as on 14-12-2024
- Paid Up Capital ₹ 2.23 M
as on 14-12-2024
- Company Age 29 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 6.06 M
as on 14-12-2024
- Revenue 12.76%
(FY 2023)
- Profit -138.12%
(FY 2023)
- Ebitda -93.92%
(FY 2023)
- Net Worth -7.91%
(FY 2023)
- Total Assets 7.65%
(FY 2023)
About Koh-E-Fiza Hospital And Research
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 7.00 M and a paid-up capital of Rs 2.23 M.
The company currently has active open charges totaling ₹6.06 M.
Shaheen Mumtaz, Jameel Ahmed, Hunaid Kagalwalla, and Three other members serve as directors at the Company.
- CIN/LLPIN
U85110MP1995PTC009994
- Company No.
009994
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Sep 1995
- Date of AGM
23 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- LocationBhopal, Madhya Pradesh
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Koh-E-Fiza Hospital And Research?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jameel Ahmed  | Managing Director | 26-Sep-1995 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shaheen Mumtaz | Director | 26-Sep-1995 | Current |
| Hunaid Kagalwalla | Director | 26-Sep-1995 | Current |
| Moiz Husain | Director | 26-Sep-1995 | Current |
| Manju Gaur | Director | 22-Oct-2009 | Current |
| Iftikhar Khan | Director | 26-Sep-1995 | Current |
Financial Performance of Koh-E-Fiza Hospital And Research.
Koh-E-Fiza Hospital And Research Pvt Ltd, for the financial year ended 2023, experienced significant growth in revenue, with a 12.76% increase. The company also saw a substantial fall in profitability, with a 138.12% decrease in profit. The company's net worth dipped by a decrease of 7.91%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Koh-E-Fiza Hospital And Research?
In 2023, Koh-E-Fiza Hospital And Research had a public holding of 52.81%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bombay Mercartile Co-Oprative Bank Ltd. Creation Date: 27 Sep 1996 | ₹6.06 M | Open |
How Many Employees Work at Koh-E-Fiza Hospital And Research?
Unlock and access historical data on people associated with Koh-E-Fiza Hospital And Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Koh-E-Fiza Hospital And Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Koh-E-Fiza Hospital And Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
